Price T Rowe Associates Inc /Md/

13F Holdings History for Avidity Biosciences, Inc. - COMMON STOCK (RNA)

Symbol: RNA on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 9.79M shares
Security Ownership: 7.1%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Associates, Inc. ownership in Avidity Biosciences, Inc. COMMON STOCK (RNA)

2025-11-14 - T. Rowe Price Associates, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.79M shares of Avidity Biosciences, Inc. COMMON STOCK (RNA). This represents 7.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
T. Rowe Price Associates, Inc.	7.1%		$426M	9.79M			$43.57	13G/A	9/30/2025	14 Nov 2025 12:19:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.05%	0%	$426M	9.79M	-1,021,310	-9.45%	$43.57	Q3 2025
6/30/2025	0.03%	0%	$307M	10.8M	-529,371	-4.67%	$28.40	Q2 2025
3/31/2025	0.04%	+0%	$335M	11.3M	+295,275		$29.52	Q1 2025
12/31/2024	0.04%	+0%	$321M	11M	+408,861	+3.84%	$29.08	Q4 2024
9/30/2024	0.06%	0%	$488M	10.6M	-282,664	-2.59%	$45.93	Q3 2024
6/30/2024	0.05%	+0.02%	$446M	10.9M	+3,487,519	+46.9%	$40.85	Q2 2024
3/31/2024	0.02%	+0%	$190M	7.43M	+516,446	+7.47%	$25.52	Q1 2024
12/31/2023	0.01%		$62.6M	6.91M			$9.05	Q4 2023
9/30/2023	0.01%	0%	$42.2M	6.62M	-67,818	-1.01%	$6.38^*	Q3 2023
6/30/2023	0.01%	0%	$74.1M	6.68M	-180,144	-2.62%	$11.09	Q2 2023
3/31/2023	0.02%	+0%	$105M	6.86M	+157,098	+2.34%	$15.35	Q1 2023
12/31/2022	0.02%	+0.01%	$149M	6.71M	+1,538,264	+29.8%	$22.19	Q4 2022
9/30/2022	0.01%	-0.01%	$84.4M	5.17M	-2,714,102	-34.4%	$16.33	Q3 2022
6/30/2022	0.01%	0%	$115M	7.88M	-102,410	-1.28%	$14.53	Q2 2022
3/31/2022	0.01%	+0%	$147M	7.99M	+253,689	+3.28%	$18.47	Q1 2022
12/31/2021	0.02%	+0%	$184M	7.73M	+641,196	+9.04%	$23.77	Q4 2021
9/30/2021	0.02%	+0.01%	$175M	7.09M	+4,553,579	+179%	$24.63	Q3 2021
6/30/2021	0.01%	+0%	$62.7M	2.54M	+779,336	+44.3%	$24.71	Q2 2021
3/31/2021	0%	+0%	$38.3M	1.76M	+812,897	+86%	$21.81	Q1 2021
12/31/2020	0%	0%	$24.1M	945K	-12,813	-1.34%	$25.52	Q4 2020
9/30/2020	0%	+0%	$27M	958K	+7,251	+0.76%	$28.15	Q3 2020
6/30/2020	0%	+0%	$26.9M	950K	+950,400	NEW	$28.26	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.